Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$2.92 - $5.74 $335,718 - $659,939
-114,972 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$4.98 - $6.63 $572,560 - $762,264
114,972 New
114,972 $604,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.